Sunday 17 December 2017

Smurfits back bio-tech venture


Businessman Michael Smurfit has invested €300,000 in Dublin-based biotech firm Inflection Biosciences, with his son, Michael Smurfit Jnr, joining the board of the company.

Inflection is an early-stage company that is developing cancer treatments.

Chief executive and co-founder Darren Cunningham confirmed that Mr Smurfit Jnr had joined the company as part of a €725,000 fundraising initiative that the firm recently closed.

Promoted articles

Entertainment News